HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoshi Tanaka Selected Research

3- ((4- (2- styrylphenoxy)butanoyl)- 4- hydroxyprolyl)thiazolidine

10/2021Prolyl oligopeptidase participates in the cytosine arabinoside-induced nuclear translocation of glyceraldehyde 3-phosphate dehydrogenase in a human neuroblastoma cell line.
9/2017The prolyl oligopeptidase inhibitor SUAM-14746 attenuates the proliferation of human breast cancer cell lines in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoshi Tanaka Research Topics

Disease

54Neoplasms (Cancer)
07/2022 - 10/2002
16Pain (Aches)
01/2022 - 01/2005
15Inflammation (Inflammations)
01/2022 - 05/2003
12Infections
10/2022 - 10/2012
9Stroke (Strokes)
01/2021 - 01/2010
8Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 08/2010
8Postoperative Pain
01/2020 - 07/2005
7Adenocarcinoma
01/2022 - 02/2011
7Osteoporosis
12/2021 - 01/2016
7Wounds and Injuries (Trauma)
06/2020 - 10/2012
6Hepatocellular Carcinoma (Hepatoma)
05/2022 - 09/2015
6Hemorrhage
01/2021 - 01/2011
6Carcinoma (Carcinomatosis)
12/2020 - 02/2011
6Hypersensitivity (Allergy)
01/2019 - 06/2002
6Glioma (Gliomas)
10/2014 - 01/2005
5Arthritis (Polyarthritis)
06/2013 - 03/2005
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2020
4Hypoxia (Hypoxemia)
01/2022 - 07/2011
4Type 2 Diabetes Mellitus (MODY)
12/2021 - 11/2017
4Cysts
01/2021 - 11/2016
4Breast Neoplasms (Breast Cancer)
12/2020 - 06/2006
4Lymphoma (Lymphomas)
04/2018 - 07/2006
4Paralysis (Palsy)
05/2017 - 11/2004
4Stomach Neoplasms (Stomach Cancer)
01/2014 - 07/2011
4Mastocytoma
11/2008 - 05/2003
3Proteinuria
01/2022 - 06/2020
3Neuralgia (Stump Neuralgia)
01/2022 - 01/2009
3Pneumonia (Pneumonitis)
01/2022 - 07/2017
3Neoplasm Metastasis (Metastasis)
04/2021 - 08/2010
3Carcinogenesis
01/2021 - 11/2013
3Glioblastoma (Glioblastoma Multiforme)
10/2020 - 07/2008
3Lung Neoplasms (Lung Cancer)
01/2020 - 11/2017
3Vasculitis (Vasculitides)
12/2019 - 01/2018
3Obesity
01/2019 - 01/2010
3Spinal Cord Diseases
11/2018 - 11/2004
3Ovarian Neoplasms (Ovarian Cancer)
10/2018 - 08/2012
3Hypertension (High Blood Pressure)
01/2017 - 08/2008
3Peritonitis
01/2016 - 05/2004
3Schizophrenia (Dementia Praecox)
10/2015 - 06/2004
3Leukemia
04/2013 - 02/2010

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2010
10Messenger RNA (mRNA)IBA
10/2020 - 10/2002
9Histamine (Histamine Dihydrochloride)FDA Link
12/2022 - 06/2002
9CytokinesIBA
10/2021 - 10/2002
8Anesthetics (Anesthetic Agents)IBA
01/2022 - 01/2005
7Biomarkers (Surrogate Marker)IBA
02/2022 - 02/2009
6Pharmaceutical PreparationsIBA
12/2022 - 10/2011
6Zoledronic Acid (Zometa)FDA Link
01/2022 - 01/2016
6Immunoglobulin E (IgE)IBA
01/2021 - 11/2005
6Analgesics (Analgesic Drugs)IBA
01/2019 - 07/2005
6Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 03/2005
5MethyltransferasesIBA
10/2020 - 01/2005
5Claudin-4IBA
10/2018 - 07/2011
5Clostridium enterotoxinIBA
10/2018 - 12/2011
5salicylhydroxamic acid (SHAM)IBA
09/2017 - 07/2011
5Tight Junction ProteinsIBA
10/2016 - 11/2009
5ClaudinsIBA
10/2016 - 08/2010
4Immune Checkpoint InhibitorsIBA
07/2022 - 01/2020
4RNA (Ribonucleic Acid)IBA
05/2022 - 09/2005
4CreatinineIBA
01/2022 - 01/2019
4Prolyl OligopeptidasesIBA
10/2021 - 04/2013
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 10/2002
4Claudin-3IBA
10/2018 - 03/2012
4Biological ProductsIBA
01/2018 - 01/2004
3pembrolizumabIBA
07/2022 - 01/2021
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
05/2022 - 01/2018
3Interleukin-6 (Interleukin 6)IBA
02/2022 - 01/2007
3Calcitonin Gene-Related PeptideIBA
01/2022 - 11/2014
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2016
3ErbB Receptors (EGF Receptor)IBA
01/2022 - 08/2012
3Histones (Histone)IBA
01/2022 - 05/2012
3GadoliniumIBA
01/2021 - 01/2018
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 10/2006
3Temozolomide (Temodar)FDA LinkGeneric
10/2020 - 06/2012
3ProstaglandinsIBA
01/2019 - 05/2005
3Claudin-1IBA
08/2016 - 12/2011
3OccludinIBA
08/2016 - 07/2011
3EnzymesIBA
01/2016 - 11/2003
3Carboplatin (JM8)FDA LinkGeneric
10/2015 - 11/2005
3InterleukinsIBA
08/2014 - 01/2007
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2014 - 08/2005
3Dinoprostone (PGE2)FDA Link
02/2014 - 05/2003
3Protein Kinase CIBA
12/2011 - 07/2011
3AntigensIBA
01/2010 - 05/2005
3Prostaglandins EIBA
11/2008 - 05/2003
3AcidsIBA
04/2006 - 10/2003

Therapy/Procedure

38Therapeutics
02/2022 - 01/2005
18Drug Therapy (Chemotherapy)
07/2022 - 11/2005
8Transcranial Direct Current Stimulation
01/2020 - 07/2011
5Laminoplasty
05/2020 - 11/2004
4Immunotherapy
05/2022 - 07/2011
3Renal Dialysis (Hemodialysis)
10/2022 - 05/2019
3Radiotherapy
01/2021 - 06/2012
3Transcranial Magnetic Stimulation
01/2021 - 02/2017
3Spinal Fusion (Spondylosyndesis)
06/2020 - 01/2018
3Glycemic Control
06/2020 - 11/2017
3Decompression
05/2017 - 11/2004
3Electrodes (Electrode)
01/2016 - 11/2007
3Lasers (Laser)
04/2013 - 10/2005
3Epidural Analgesia
06/2008 - 07/2005